Learn More
Apexbio Technology LLC Ibandronate sodium 138926-19-9 10mM (in 1mL H2O)

Supplier: Apexbio Technology LLC B17725.1
Ibandronate sodium (CAS 138926-19-9) is a nitrogen-containing bisphosphonate that selectively inhibits farnesyl pyrophosphate synthase within the mevalonate pathway thereby disrupting osteoclast-mediated bone resorption By impairing osteoclast function and survival ibandronate sodium effectively reduces bone turnover This compound is widely utilized in biomedical research to investigate mechanisms related to bone metabolism remodeling and diseases characterized by excessive bone resorption such as osteoporosis Its precise inhibitory profile makes it a valuable tool for studies on osteoclast biology and bisphosphonate pharmacodynamics
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.